Alexander Natz

Alexander Natz

Alexander Natz is Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Why rare diseases must remain in the political spotlight Partner Content
26 Nov EU Institutions
Why rare diseases must remain in the political spotlight
A new political mandate must mean political attention for rare diseases, combined with a comprehensive and collaborative approach
How the EU can strengthen pharmaceutical competitiveness Partner Content
03 Oct EU Institutions
How the EU can strengthen pharmaceutical competitiveness
By prioritising competitiveness and regulatory efficiency, the EU can empower its pharmaceutical sector to innovate and excel, addressing rare diseases and unmet needs.
Looking out for the little guy: Why we need a competitive EU pharmaceutical framework for small and mid-sized companies Partner Content
06 Sep
Looking out for the little guy: Why we need a competitive EU pharmaceutical framework for small and mid-sized companies
The EU must provide enough and predictable incentives to encourage innovation and reward investments in the European Pharmaceutical market.
Thoughtful Calibration
02 Mar
Thoughtful Calibration
By fostering collaboration between different stakeholders such as industry, patients, and ERNs, among others, we can develop novel therapies and address the unmet needs, writes Alexander Natz
Learning from the rare disease community Partner Content
25 Feb
Learning from the rare disease community
Europe’s pharmaceutical entrepreneurs are taking the lessons learned from this community to develop health innovation which would not have been dreamt of a few decades ago
Rare Diseases: Celebrating patient-centred innovation Partner Content
26 Feb
Rare Diseases: Celebrating patient-centred innovation
After a challenging year, Rare Disease Day 2021 is a wonderful opportunity to recognise the incredible efforts and achievements of patients, their associations and the scientific community, explains Alexander Natz.